1751. What is the expected benefit of patient-centric clinical development in oncology?. Issue 3 (4th May 2022) Authors: Serra, Alessandra; Mozgunov, Pavel; Jaki, Thomas; Rigat, Fabio Journal: Journal of biopharmaceutical statistics Issue: Volume 32:Issue 3(2022) Page Start: 414 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
1752. When is a seamless study desirable? Case studies from different pharmaceutical sponsors. (29th May 2014) Authors: Cuffe, Robert L.; Lawrence, David; Stone, Andrew; Vandemeulebroecke, Marc Journal: Pharmaceutical statistics Issue: Volume 13:Number 4(2014:Jul./Aug.) Page Start: 229 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
1753. Why are two mistakes not worse than one? A proposal for controlling the expected number of false claims. (20th April 2016) Authors: Jaki, Thomas; Parry, Alice Other Names: Kieser Meinhard guestEditor. Journal: Pharmaceutical statistics Issue: Volume 15:Number 4(2016) Page Start: 362 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
1754. Wilcoxon's signed‐rank statistic: what null hypothesis and why it matters. (18th June 2014) Authors: Li, Heng; Johnson, Terri Journal: Pharmaceutical statistics Issue: Volume 13:Number 5(2014:Sep./Oct.) Page Start: 281 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
1755. Win statistics (win ratio, win odds, and net benefit) can complement one another to show the strength of the treatment effect on time‐to‐event outcomes. (27th June 2022) Authors: Dong, Gaohong; Huang, Bo; Verbeeck, Johan; Cui, Ying; Song, James; Gamalo‐Siebers, Margaret; Wang, Duolao; Hoaglin, David C.; Seifu, Yodit; Mütze, Tobias; Kolassa, John Journal: Pharmaceutical statistics Issue: Volume 22:Number 1(2023) Page Start: 20 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
1756. Zmax test for delayed effect in immuno-oncology clinical trials. Issue 2 (3rd March 2020) Authors: Yang, Miao; Hua, Zhaowei; Xue, Lan; Hu, Mingxiu Journal: Journal of biopharmaceutical statistics Issue: Volume 30:Issue 2(2020) Page Start: 244 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
1757. Α Markov model for longitudinal studies with incomplete dichotomous outcomes. (5th December 2016) Authors: Efthimiou, Orestis; Welton, Nicky; Samara, Myrto; Leucht, Stefan; Salanti, Georgia Journal: Pharmaceutical statistics Issue: Volume 16:Number 2(2017) Page Start: 122 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗